Commensal bacteria directly suppress in vitro degranulation of mast cells in a MyD88-independent manner

Bioscience, Biotechnology and Biochemistry

Volumn 78, Issue 10, 2014, Pages 1669-1676

  Kasakura, Kazumi ^a,b,c   Takahashi, Kyoko ^a   Itoh, Tomoko ^a   Hosono, Akira ^a   Momose, Yoshika ^d   Itoh, Kikuji ^d   Nishiyama, Chiharu ^b,c   Kaminogawa, Shuichi ^a  

^a NIHON UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Allergy; Commensal bacteria; Degranulation; Mast cells

Indexed keywords

ALLERGIES; BIOLOGY;

ALLERGIC DISEASE; DEGRANULATION; ENTEROCOCCUS FAECALIS; EPIDEMIOLOGIC-STUDY; HIGH-AFFINITY IGE RECEPTORS; MAST CELLS; MICROBIOTAS; MOLECULAR MECHANISM;

BACTERIA;

ENTEROCOCCUS FAECALIS;

MYELOID DIFFERENTIATION FACTOR 88;

ANIMAL; CYTOLOGY; DEGRANULATION; ENTEROCOCCUS FAECALIS; FEMALE; INTRACELLULAR SPACE; MAST CELL; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEGRANULATION; ENTEROCOCCUS FAECALIS; FEMALE; INTRACELLULAR SPACE; MAST CELLS; MICE; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION;

EID: 84923582025     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1080/09168451.2014.930327     Document Type: Article

References (40)

1. Bashir ME, Louie S, Shi HN, Nagler-Anderson C. Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J. Immunol. 2004;172:6978-6987.
2. Kim YG, Udayanga KG, Totsuka N, Weinberg JB, Núñez G, Shibuya A. Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE2. Cell Host Microbe. 2014;15:95-102.
3. Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc. Nat. Acad. Sci. USA. 1998;95:6578-6583.
4. Eckburg PB, Lepp PW, Relman DA. Archaea and their potential role in human disease. Infect. Immun. 2003;71:591-596.
5. Human Microbiome Project Consortium. Nature. 2012;486:207-214.
6. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Jian M, Zhou Y, Li Y, Zhang X, Qin N, Yang H, Wang J, Brunak S, Dore J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59-65.
7. Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 2001;108:516-520.
8. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 2001;107:129-134.
9. Bottcher MF, Nordin EK, Sandin A, Midtvedt T, Bjorksten B. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin. Exp. Allergy. 2000;30:1590-1596.
10. Woodcock A, Moradi M, Smillie FI, Murray CS, Burnie JP, Custovic A. Clostridium difficile, atopy and wheeze during the first year of life. Pediatr. Allergy Immunol. 2002;13:357-360.
11. Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, Adams H, van Ree R, Stobberingh EE. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut. 2007;56:661-667.
12. Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S. Differences in bifidobacterium flora composition in allergic and healthy infants. J. Allergy Clin. Immunol. 2001;108:144-145.
13. Stsepetova J, Sepp E, Julge K, Vaughan E, Mikelsaar M, de Vos WM. Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunol. Med. Microbiol. 2007;51:260-269.
14. Gore C, Munro K, Lay C, Bibiloni R, Morris J, Woodcock A, Custovic A, Tannock GW. Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J. Allergy Clin. Immunol. 2008;121:135-140.
15. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 1997;159:1739-1745.
16. Gaboriau-Routhiau V, Raibaud P, Dubuquoy C, Moreau MC. Colonization of gnotobiotic mice with human gut microflora at birth protects against Escherichia coli heat-labile enterotoxin-mediated abrogation of oral tolerance. Pediatr. Res. 2003;54:739-746.
17. Smith K, McCoy KD, Macpherson AJ. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin. Immunol. 2007;19:59-69.
18. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 2009;9:313-323.
19. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357:1076-1079.
20. Kinet JP. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu. Rev. Immunol. 1999;17:931-972.
21. Galli SJ, Maurer M, Lantz CS. Mast cells as sentinels of innate immunity. Curr. Opin. Immunol. 1999;11:53-59.
22. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 2008;8:478-486.
23. Palm NW, Rosenstein RK, Medzhitov R. Allergic host defences. Nature. 2012;484:465-472.
24. Sandig H, Bulfone-Paus S. TLR signaling in mast cells: common and unique features. Front Immunol. 2012;3:185-198.
25. Magerl M, Lammel V, Siebenhaar F, Zuberbier T, Metz M, Maurer M. Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells. Exp. Dermatol. 2008;17:427-435.
26. Saturnino SF, Prado RO, Cunha-Melo JR, Andrade MV. Endotoxin tolerance and cross-tolerance in mast cells involves TLR4, TLR2 and FcepsilonR1 interactions and SOCS expression: perspectives on immunomodulation in infectious and allergic diseases. BMC Infect. Dis. 2010;10:240.
27. Mabbott NA, Donaldson DS, Ohno H, Williams IR, Mahajan A. Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal. Immunol. 2013;6:666-677.
28. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2001;2:361-367.
29. Nazli A, Wang A, Steen O, Prescott D, Lu J, Perdue MH, Soderholm JD, Sherman PM, McKay DM. Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia. Infect. Immun. 2006;74:192-201.
30. Wesolowski J, Caldwell V, Paumet F. A novel function for SNAP29 (synaptosomal-associated protein of 29 kDa) in mast cell phagocytosis. PLoS One. 2012;7:e49886.
31. Terada T, Nunomura S, Shimokawa T, Murayama K, Era S, Kondo N, Ra C. FcepsilonRI-induced mast cell cytokine production critically involves an aspartic acid residue (D234) in the C-terminal intracellular domain of the FcepsilonRIbeta chain. Biochem. Biophys. Res. Commun. 2011;410:744-748.
32. Kasakura K, Takahashi K, Aizawa T, Hosono A, Kaminogawa S. A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells. Int. Arch. Allergy Immunol. 2009;150:359-369.
33. Kufer TA, Banks DJ, Philpott DJ. Innate immune sensing of microbes by Nod proteins. Ann. N.Y. Acad. Sci. 2006;1072:19-27.
34. Oprea SF, Zaidi N, Donabedian SM, Balasubramaniam M, Hershberger E, Zervos MJ. Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis. J. Antimicrob. Chemother. 2004;53:626-630.
35. Yoshioka M, Fukuishi N, Iriguchi S, Ohsaki K, Yamanobe H, Inukai A, Kurihara D, Imajo N, Yasui Y, Matsui N, Tsujita T, Ishii A, Seya T, Takahama M, Akagi M. Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through Toll-like receptor 2. J. Allergy Clin. Immunol. 2007;120:452-461.
36. Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature. 2008;454:445-454.
37. Foreman JC, Mongar JL, Gomperts BD. Calcium ionophores and movement of calcium ions following the physiological stimulus to a secretory process. Nature. 1973;245:249-251.
38. Baba Y, Nishida K, Fujii Y, Hirano T, Hikida M, Kurosaki T. Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nat. Immunol. 2008;9:81-88.
39. Nishida K, Yamasaki S, Ito Y, Kabu K, Hattori K, Tezuka T, Nishizumi H, Kitamura D, Goitsuka R, Geha RS, Yamamoto T, Yagi T, Hirano T. FcεRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J. Cell Biol. 2005;170:115-126.
40. Berenbaum F, Humbert L, Bereziat G, Thirion S. Concomitant recruitment of ERK1/2 and p38 MAPK signalling pathway is required for activation of cytoplasmic phospholipase A2 via ATP in articular chondrocytes. J. Biol. Chem. 2003;278:13680-13687.